Heidi scaling new heights in Asia with bottom-up adoption
AI Care Partner Heidi is scaling fast across Asia. GM Asia Keppell Smith outlines the company's strategy for the region.
Health AI
Abu Dhabi signs 22 life sciences agreements, with AI running through genomics, drug discovery and biobanking
The delegation, spanning San Francisco, San Diego and Los Angeles, brought together more than 40 senior representatives from 16 Abu Dhabi government, healthcare, research and industry organisations.
“Technology should support clinical judgement, not replace it”: inside Siloam’s Hospital of the Future
In an exclusive interview, Siloam President Director David Utama discusses the hospital network's push to build its own AI foundation, and efforts to reverse Indonesia's medical tourism outflow.
The doctor Is still in the loop: Valeo Health on AI, data residency, and the future of Gulf preventive care
In an interview with HealthTechAsia, Sundeep Sahni, Co-Founder of Valeo Health, explains how the platform is scaling preventive care across the GCC.
Heidi launches in UAE with 80,000 consultations already logged
Marking its entry into the GCC, Heidi's UAE launch is anchored by a strategic partnership with women's health clinic Nabta.
Between innovation and precaution: what Indonesia’s emerging AI governance framework signals for Asia
Indonesia is beginning to ask the right questions about AI governance in healthcare. HealthTechAsia's Vishnu Narayan asks whether its approach could offer a model for the rest of ASEAN.
Saudi Arabia calls for member state primacy in AI governance at UN General Assembly
Speaking for the Arab Group, Saudi Arabia said ethical frameworks for AI should be grounded in transparency, reliability and accountability.
M42’s National Reference Laboratory deploys AI-powered prostate cancer diagnostics with Qritive
With prostate cancer among the most commonly diagnosed cancers in men, the companies frame the deployment against rising diagnostic demand and pathology workforce pressures.
Cleveland Clinic Abu Dhabi and Owkin launch AI platform for prostate cancer research and clinical support
Aila is built on Owkin's K Pro platform, described as an agentic system purpose-built for biology, and operates through a natural-language interface that allows physicians to query clinical datasets directly.